Treatment of non-muscle invasive bladder cancer.

被引：1
|
作者：
Danforth, Kim N.
Lee, Janet S.
Luong, Tiffany Q.
Munoz-Plaza, Corrine E.
Hahn, Erin Elizabeth
Mittman, Brian S.
Loo, Ronald K.
Williams, Stephen G.
机构：
[1] Kaiser Permanents Southern Calif, Pasadena, CA USA
[2] Kaiser Permanente So Calif, Downey, CA USA
[3] Kaiser Permanente So Calif, Riverside, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e15505
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15505
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Intravesical Admistration of Gemcitabine for the Treatment of non-muscle invasive Bladder Cancer
    Spek, Annabel
    UROLOGIE, 2022, 61 (06): : 653 - 656
  • [22] INTRAVESICAL THERAPY FOLLOWING TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
    Wang, Wei
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 36 - 36
  • [23] Recirculating endovesical chemohyperthermia in the treatment of non-muscle invasive bladder cancer
    Sousa Escandon, Alejandro
    Mata, Juan Leon
    Sousa-Gonzalez, Daniel
    Rodriguez Gomez, Silvia
    Pineiro Diaz, Idelfonso
    MEDICINA BALEAR, 2019, 34 (02): : 33 - 39
  • [24] Advances in intravesical therapy for the treatment of non-muscle invasive bladder cancer
    Weintraub, Michael D.
    Li, Qingdi Quentin
    Agarwal, Piyush K.
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (05) : 656 - 660
  • [25] Treatment Modalities for Non-Muscle Invasive Bladder Cancer: An Updated Review
    Mcnall, Shannon
    Hooper, Kailey
    Sullivan, Travis
    Rieger-Christ, Kimberly
    Clements, Matthew
    CANCERS, 2024, 16 (10)
  • [26] The efficacy of EORTC risk tables in Japanese patients with non-muscle invasive bladder cancer.
    Muto, Satoru
    Ieda, Takeshi
    Sugiura, Syou-ichiro
    Nakajima, Akiko
    Horiuchi, Akira
    Shimizu, Fumitaka
    Inoue, Masahiro
    Noma, Yasuo
    Kitamura, Kousuke
    Saito, Keisuke
    Isotani, Shuji
    Ide, Hisamitsu
    Yamaguchi, Raizo
    Horie, Shigeo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [27] Adverse effects and discontinuation of pembrolizumab in BCG refractory non-muscle invasive bladder cancer.
    Golijanin, Borivoj
    Malshy, Kamil
    Golijanin, Borivoj
    Bhatt, Vikas
    Lagos, Galina
    Amin, Ali
    De Souza, Andre Luiz
    Cheng, Liang
    Mega, Anthony E.
    Golijanin, Dragan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [28] Active Surveillance for non-muscle invasive Bladder Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2024, 55 (04)
  • [29] Non-muscle invasive bladder cancer risk stratification
    Isharwal, Sumit
    Konety, Badrinath
    INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 289 - 296
  • [30] Immune Therapies in Non-Muscle Invasive Bladder Cancer
    Philip L. Ho
    Stephen B. Williams
    Ashish M. Kamat
    Current Treatment Options in Oncology, 2015, 16
12345